Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a
leading specialty insurance provider, today announced financial
results for the first quarter of 2023.
David Clare, President and CEO of Trisura,
stated, “Trisura reported strong performance in the quarter with
operating net income of $28.6 million, or $0.61 per share.
Quarterly net income of $14.0 million, or $0.30 per share, was
impacted both by the implementation of new IFRS standards and the
run-off of a US program.
Expansion of distribution relationships and
maturation of our platform drove increased market share and
resulted in insurance revenue growth of 58.3%. In Canada,
disciplined underwriting yielded a combined ratio of 80.7%. Our US
fronting business produced $459.3 million of insurance revenue and
reported deferred fee income of $35.9 million.
Net investment income grew 150.3% in the
quarter, reflecting higher yields and an increased size of the
investment portfolio.
Our business remains well-capitalized, supported
by surplus cash, a $50 million undrawn revolver, a 12.8% debt to
capital ratio and a conservatively positioned investment
portfolio.
Financial Highlights
- Insurance
revenue growth of 58.3% in Q1 2023 reflected sustained momentum
across North America.
- Net income of
$14.0 million in the quarter fell compared to prior period as a
result of losses on the run-off of a US program. Operating net
income(1) of $28.6 million in the quarter grew by 38.5% compared to
prior period, driven by profitable growth in Canada and core
operations in the US.
- EPS of $0.30 in
Q1 2023 compared to $0.55 in Q1 2022. Operating EPS(2) of $0.61 for
the quarter compared to $0.49 in the prior year.
- Book value per
share(3) of $11.15 increased 25.4% from March 31, 2022, driven by
our July 2022 equity raise, strong Canadian earnings and foreign
currency movements, but diluted by the write down on reinsurance
recoverables and unrealized losses on investments.
- ROE of 4.1%
compared to 18.7% in Q1 2022, below our mid-teens target as a
result of the write down on reinsurance recoverables and losses
associated with the run-off program. Operating ROE of 20.6%
exceeded our target, demonstrating the strength of our core
operations despite significant growth and a larger capital
base.
Amounts in C$ millions |
Q1 2023 |
Q1 2022 |
Variance |
Insurance revenue |
639.1 |
|
403.7 |
|
58.3 |
% |
Net income |
14.0 |
|
23.3 |
|
(40.1 |
%) |
Operating net income(1) |
28.6 |
|
20.7 |
|
38.5 |
% |
EPS – diluted, $ |
0.30 |
|
0.55 |
|
(45.5 |
%) |
Operating EPS – diluted, $(2) |
0.61 |
|
0.49 |
|
24.5 |
% |
Book value per share, $(3) |
11.15 |
|
8.89 |
|
25.4 |
% |
Debt-to-Capital ratio(3)(10) |
12.8 |
% |
17.4 |
% |
(4.6 |
pts) |
LTM ROE |
4.1 |
% |
18.7 |
% |
(14.6 |
pts) |
Operating LTM ROE(4) |
20.6 |
% |
18.2 |
% |
2.4 |
pts |
Combined ratio – Canada |
80.7 |
% |
77.2 |
% |
3.5 |
pts |
Fronting operational ratio – US(3) |
111.1 |
% |
70.8 |
% |
40.3 |
pts |
Adjusted Fronting operational ratio – US(5) |
86.0 |
% |
N/A |
|
N/A |
|
Insurance Operations
- Insurance
revenue in Canada increased by 33.2% in the quarter, reflecting
increased market share, expansion of distribution relationships,
new fronting arrangements and the benefit of stable market pricing
conditions in certain lines of business. Strong underwriting
performance across all lines contributed to a combined ratio of
80.7% and an ROE of 28.4% in Q1 2023.
- Insurance
revenue in the US of $459.3 million in the quarter, increased by
70.9%, reflecting favourable market conditions and maturation of
existing programs. Fee income(6) of $18.0 million in the quarter
increased by 29.6% compared to $13.9 million in Q1 2022. Net loss
of ($1.7) million in the quarter was driven by losses on the
run-off of a US program. The negative ROE was driven by the write
down on reinsurance recoverables in Q4 2022 and losses on the
run-off program. Excluding the write down and run-off, adjusted net
income in Q1 2023 was $9.9 million driving a 12.8% adjusted
ROE.
Capital
- The Minimum
Capital Test ratio(7) of our regulated Canadian subsidiary was 240%
as at March 31, 2023 (233% as at December 31, 2022), which
comfortably exceeded regulatory requirements(8) of 150%.
- As at December
31, 2022, the Risk-Based Capital of the regulated insurance
companies of Trisura US were in excess of the various company
action levels of the states in which they are licensed.
- Consolidated
debt-to-capital ratio of 12.8% as at March 31, 2023 is below our
long-term target of 20.0%.
- Surplus cash and
an undrawn $50 million revolving credit facility.
Investments
- Interest and
dividend income rose 150.3% in the quarter compared to Q1 2022. The
portfolio benefited from higher yields and increased capital
generated from strong operational performance and the July 2022
equity raise.
Governance
- Appointed Anik
Lanthier to the Company’s Board of Directors.
Earnings Conference Call
Trisura will host its First Quarter Earnings
Conference Call to review financial results at 9:00 a.m. ET on
Friday, May 12th, 2023.
To listen to the call via live audio webcast,
please follow the link below:
https://edge.media-server.com/mmc/p/strobz89A replay of the call
will be available through the link above.
Investor Day
Immediately following the Company’s Annual
General Meeting, which will be held on Thursday, June 1st, 2023 at
2:00 pm (Eastern Time) at the North Tower, 200 Bay Street, Suite
1600 in Toronto, Trisura will host an investor presentation to
discuss long-term strategy and market conditions.
To listen to the presentation via live audio
webcast, please follow the link below:
https://web.lumiagm.com/448062087
About Trisura Group
Trisura Group Ltd. is a specialty insurance
provider operating in the Surety, Risk Solutions, Corporate
Insurance, and Fronting business lines of the market. Trisura has
investments in wholly owned subsidiaries through which it conducts
insurance and reinsurance operations. Those operations are
primarily in Canada (“Trisura Canada”) and the United States
(“Trisura US”). Trisura Group Ltd. is listed on the Toronto Stock
Exchange under the symbol “TSU”.
Further information is available at
http://www.trisura.com. Important information may be disseminated
exclusively via the website; investors should consult the site to
access this information. Details regarding the operations of
Trisura Group Ltd. are also set forth in regulatory filings. A copy
of the filings may be obtained on Trisura Group’s SEDAR profile at
www.sedar.com.
For more information, please contact:
Name: Bryan SinclairTel: 416 607 2135Email:
bryan.sinclair@trisura.com
Trisura Group
Ltd.Condensed Interim Consolidated Statements of
Financial PositionAs at March 31, 2023 and
December 31, 2022(in thousands of Canadian
dollars, except as otherwise noted)
As at |
March 31, 2023 |
December 31, 2022 |
Cash and cash equivalents |
368,210 |
406,368 |
Investments |
824,365 |
765,375 |
Other Assets |
45,863 |
61,852 |
Reinsurance contract assets |
1,702,484 |
1,527,799 |
Capital assets and intangible assets |
18,691 |
19,529 |
Deferred tax assets |
17,461 |
17,942 |
Total assets |
2,977,074 |
2,798,865 |
Insurance contract liabilities |
2,318,964 |
2,165,103 |
Other liabilities |
70,652 |
65,111 |
Loan payable |
75,000 |
75,000 |
Total liabilities |
2,464,616 |
2,305,214 |
Shareholders' equity |
512,458 |
493,651 |
Total liabilities and shareholders' equity |
2,977,074 |
2,798,865 |
Trisura Group
Ltd.Condensed Interim Consolidated Statements of
Comprehensive IncomeFor the three months ended
March 31(in thousands of Canadian dollars, except
as otherwise noted)
|
Q1 2023 |
Q1 2022 |
Insurance revenue |
639,100 |
|
403,669 |
|
Insurance service expenses |
(500,443 |
) |
(313,450 |
) |
Net expense from reinsurance contracts assets |
(122,942 |
) |
(63,313 |
) |
Insurance service result |
16,715 |
|
26,906 |
|
Net investment income |
10,071 |
|
4,023 |
|
Net losses |
(2,215 |
) |
(474 |
) |
Net credit impairment losses |
(149 |
) |
- |
|
Finance (expenses) income from insurance contracts |
(36,628 |
) |
8,822 |
|
Finance income (expenses) from reinsurance contracts |
31,902 |
|
(8,065 |
) |
Net Insurance and investment result |
19,696 |
|
31,212 |
|
Other income |
5,178 |
|
4,342 |
|
Other operating expenses |
(5,432 |
) |
(4,335 |
) |
Other finance costs |
(600 |
) |
(591 |
) |
Income before income taxes |
18,842 |
|
30,628 |
|
Income tax expense |
(4,866 |
) |
(7,290 |
) |
Net income |
13,976 |
|
23,338 |
|
Other comprehensive income (loss) |
5,921 |
|
(21,054 |
) |
Comprehensive income |
19,897 |
|
2,284 |
|
Trisura Group
Ltd.Condensed Interim Consolidated Statements of
Cash FlowsFor the three months ended March
31(in thousands of Canadian dollars, except as
otherwise noted)
|
Q1 2023 |
Q1 2022 |
Net income |
13,976 |
|
23,338 |
|
Non-cash items |
5,232 |
|
6,096 |
|
Change in working capital |
(1,046 |
) |
1,009 |
|
Realized losses (gains) |
245 |
|
(3,053 |
) |
Income taxes paid |
(3,837 |
) |
(11,634 |
) |
Interest paid |
(127 |
) |
(499 |
) |
Net cash from operating activities |
14,443 |
|
15,257 |
|
Proceeds on disposal of investments |
31,601 |
|
53,589 |
|
Purchases of investments |
(79,987 |
) |
(100,983 |
) |
Net purchases of capital and intangible assets |
(177 |
) |
(290 |
) |
Net cash used in investing activities |
(48,563 |
) |
(47,684 |
) |
Shares issued |
711 |
|
551 |
|
Shares purchased under Restricted Share Units plan |
(869 |
) |
(2,106 |
) |
Lease payments |
(512 |
) |
(502 |
) |
Net cash from financing activities |
(670 |
) |
(2,057 |
) |
Net decrease in cash and cash equivalents,
and short-term securities during the period |
(34,790 |
) |
(34,484 |
) |
Cash and cash equivalents, beginning of period |
406,368 |
|
341,319 |
|
Currency translation |
(3,368 |
) |
(2,371 |
) |
Cash and cash equivalents, and short-term securities, end
of period |
368,210 |
|
304,464 |
|
Non-IFRS Financial Measures
Table 1 – Reconciliation of reported Net income to
Operating net
income(3):
reflect Net income, adjusted for certain items to normalize
earnings to core operations in order to better reflect our North
American specialty operations.
|
Q1 2023 |
Q1 2022 |
Net income |
13,976 |
|
23,338 |
|
Adjustments: |
|
|
Run-off Program |
14,691 |
|
- |
|
Impact of share based compensation |
(3,370 |
) |
(3,142 |
) |
Finance expenses (income) from insurance and reinsurance
contracts |
4,726 |
|
(757 |
) |
Net losses |
2,215 |
|
474 |
|
Net credit impairment losses |
149 |
|
- |
|
Net losses from life annuity |
- |
|
77 |
|
Tax impact of above items |
(3,774 |
) |
667 |
|
Operating net income |
28,613 |
|
20,657 |
|
Table 2 – ROE and Operating
ROE: a measure of the Company’s use of equity.
|
Q1 2023 |
Q1 2022 |
LTM net income |
18,433 |
|
64,291 |
|
LTM average equity |
449,417 |
|
342,987 |
|
ROE |
4.1 |
% |
18.7 |
% |
Operating LTM net income(4) |
92,666 |
|
62,445 |
|
LTM average equity |
449,417 |
|
342,987 |
|
Operating LTM ROE |
20.6 |
% |
18.2 |
% |
Table 3 – Reconciliation of Average
equity(9)
to LTM average equity: LTM average equity is used
in calculating Operating ROE.
|
|
Q1 2023 |
Q1 2022 |
Average equity |
439,502 |
332,856 |
Adjustments: days in quarter proration |
9,915 |
10,131 |
LTM average equity |
449,417 |
342,987 |
Footnotes
(1) See section on Non-IFRS financial measures,
Reconciliation of reported Net income to Operating net income.
Operating net income is a non-IFRS financial measure. Non-IFRS
financial measures are not standardized financial measures under
the financial reporting framework used to prepare the financial
statements of the Company to which the measure relates and might
not be comparable to similar financial measures disclosed by other
companies. Details and an explanation of how it provides useful
information to an investor can be found in table 1.
(2) This is a non-IFRS ratio, see table 10.2 in
Q1 2023 MD&A for details on composition, as well as each
non-IFRS financial measure used as a component of ratio, and an
explanation of how it provides useful information to an investor.
Non-IFRS ratios are not standardized under the financial reporting
framework used to prepare the financial statements of the Company
to which the ratio relates and might not be comparable to similar
ratios disclosed by other companies. To access MD&A, see
Trisura’s website or SEDAR at www.sedar.com.
(3) This is a supplementary financial measure.
Refer to Q1 2023 MD&A, Section 10, Operating Metrics table for
its composition.
(4) This is a non-IFRS ratio. See table 10.4 in
Q1 2023 MD&A for details on composition, as well as each
non-IFRS financial measure used as a component of ratio, and an
explanation of how it provides useful information to an
investor.
(5) This is a non-IFRS financial measure.
Adjusted figures exclude the impacts from write down of reinsurance
recoverables, and the run-off program.
(6) This is a non-IFRS financial measure. See
table 10.5.5 in Q1 2023 MDA for details on composition.
(7) This measure is calculated in accordance
with the Office of the Superintendent of Financial Institutions
Canada’s (OSFI’s) Guideline A, Minimum Capital Test.
(8) This target is in accordance with OSFI’s
Guideline A-4, Regulatory Capital and Internal Capital Targets.
(9) Average equity is calculated as the sum of
opening equity and closing equity over the last twelve months,
divided by two.
(10) The Q1 2022 metric has not been restated to
reflect the adoption of IFRS 9 and IFRS 17.
Cautionary Statement Regarding Forward-Looking
Statements and Information
Note: This news release contains
“forward-looking information” within the meaning of Canadian
provincial securities laws and “forward-looking statements” within
the meaning of applicable Canadian securities regulations.
Forward-looking statements include statements that are predictive
in nature, depend upon or refer to future events or conditions,
include statements regarding the operations, business, financial
condition, expected financial results, performance, prospects,
opportunities, priorities, targets, goals, ongoing objectives,
strategies and outlook of the Company and its subsidiaries, as well
as the outlook for North American and international economies for
the current fiscal year and subsequent periods, and include words
such as “expects,” “likely,” “anticipates,” “plans,” “believes,”
“estimates,” “seeks,” “intends,” “targets,” “projects,” “forecasts”
or negative versions thereof and other similar expressions, or
future or conditional verbs such as “may,” “will,” “should,”
“would” and “could”.
Although we believe that our anticipated future
results, performance or achievements expressed or implied by the
forward-looking statements and information are based upon
reasonable assumptions and expectations, the reader should not
place undue reliance on forward-looking statements and information
because they involve known and unknown risks, uncertainties and
other factors, many of which are beyond our control, which may
cause the actual results, performance or achievements of our
Company to differ materially from anticipated future results,
performance or achievement expressed or implied by such
forward-looking statements and information.
Factors that could cause actual results to
differ materially from those contemplated or implied by
forward-looking statements include, but are not limited to: the
impact or unanticipated impact of general economic, political and
market factors in the countries in which we do business; the
behaviour of financial markets, including fluctuations in interest
and foreign exchange rates; global equity and capital markets and
the availability of equity and debt financing and refinancing
within these markets; insurance risks including pricing risk,
concentration risk and exposure to large losses, and risks
associated with estimates of loss reserves; strategic actions
including dispositions; the ability to complete and effectively
integrate acquisitions into existing operations and the ability to
attain expected benefits; changes in accounting policies and
methods used to report financial condition (including uncertainties
associated with critical accounting assumptions and estimates); the
ability to appropriately manage human capital; the effect of
applying future accounting changes; business competition;
operational and reputational risks; technological change; changes
in government regulation and legislation within the countries in
which we operate; governmental investigations; litigation; changes
in tax laws; changes in capital requirements; changes in
reinsurance arrangements and availability and cost of reinsurance;
ability to collect amounts owed; catastrophic events, such as
earthquakes, hurricanes or pandemics; developments related to
COVID-19, including the impact of COVID-19 on the economy and
global financial markets; the possible impact of international
conflicts and other developments including terrorist acts and
cyberterrorism; risks associated with reliance on distribution
partners, capacity providers and program administrators; third
party risks; risk that models used to manage the business do not
function as expected; climate change risk; risk of economic
downturn; risk of inflation and other risks and factors detailed
from time to time in our documents filed with securities regulators
in Canada.
We caution that the foregoing list of important
factors that may affect future results is not exhaustive. When
relying on our forward-looking statements, investors and others
should carefully consider the foregoing factors and other
uncertainties and potential events. Except as required by law, the
Company undertakes no obligation to publicly update or revise any
forward-looking statements or information, whether written or oral,
that may be as a result of new information, future events or
otherwise.
Cautionary Non-IFRS and Other Financial
Measures
Reported results conform to generally accepted
accounting principles (GAAP), in accordance with IFRS. In addition
to reported results, the Company also presents certain financial
measures, including non-IFRS financial measures that are
historical, non-IFRS ratios, and supplementary financial measures,
to assess results. Non-IFRS financial measures, such as operating
net income, are utilized to assess the Company’s overall
performance. To arrive at operating results, the Company adjusts
for certain items to normalize earnings to core operations, in
order to better reflect our North American specialty operations.
Non-IFRS ratios include a non-IFRS financial measure as one or more
of its components. Examples of non-IFRS ratios include operating
diluted earnings per share and operating ROE. The Company believes
that non-IFRS financial measures and non-IFRS ratios provide the
reader with an enhanced understanding of our results and related
trends and increase transparency and clarity into the core results
of the business. Non-IFRS financial measures and non-IFRS ratios
are not standardized terms under IFRS and, therefore, may not be
comparable to similar terms used by other companies. Supplementary
financial measures depict the Company’s financial performance and
position, and are explained in this document where they first
appear, and incorporates information by reference to the Company’s
current MD&A, for the three months ended March 31, 2023. To
access MD&A, see Trisura’s website or SEDAR at www.sedar.com.
These measures are pursuant to National Instrument 52-112 Non-GAAP
and Other Financial Measures Disclosure.
Trisura (TSX:TSU)
Historical Stock Chart
From Apr 2024 to May 2024
Trisura (TSX:TSU)
Historical Stock Chart
From May 2023 to May 2024